摘要
目的探讨CD147、MMP-1、MMP-2、MMP-9、TIMP-1、TIMP-2在胶质瘤中的表达及其相关性,方法采用免疫组织化学法对78例石蜡包埋的胶质瘤组织和12例正常脑组织进行标记和分析。结果CD147、MMP-1、MMP-2、MMP-9、TIMP-1、TIMP-2的阳性率分别为62%、66%、64%、75%、59%、59%,采用Spearm an进行相关性分析,他们与胶质瘤的恶性程度均呈正相关(rs=0.2671-0.5631,P〈0.05),CD147与MMP-1、MMP-2和MMP-9呈正相关(rs=0.3481-0.4951,P〈0.05)。结论CD147、MMPS、TIMPs可以作为临床判断胶质瘤预后的分子生物学标志。
Objective:To investigate the expressions of CD147,MMP-1,MMP-2,MMP-9,TIMP-1 and TIMP-2 in human gliomas and to study their correlation.Methods: The expressions of CD147,MMP-1,MMP-2,MMP-9,TIMP-1 and TIMP-2 were assessed in paraffin-embedded specimens collected from 78 cases of gliomas and 12 cases of benign brain tissue by immunohistochemistry.Results: Their expressons were 62%,66%,64%,75.%,59%,59%.Using Spearman analysis,a significant positive correlation between CD147,MMP-1,MMP-2,MMP-9,TIMP-1,TIMP-2 and gliomas expression was found(rs=0.2671~0.5631,P〈0.01).The correlation was significant between CD147 and MMP-1,MMP-2,MMP-9(rs=0.3481~0.4951,P〈0.01).Conclusion: The results suggest that concurrent expression of CD147 and MMPs may be an important characteristic of gliomas patients which may help in the prediction of gliomas progression.
出处
《泰山医学院学报》
CAS
2010年第9期653-655,共3页
Journal of Taishan Medical College
基金
包头医药卫生基金项目(2009S1001-30)